Chongqing Mile High Biopharmaceutical

Chongqing Mile High Biopharmaceutical is an innovative biotechnology company based in Chongqing, China, focused on the development of novel therapeutics for metabolic and inflammatory diseases. The company's research and development efforts are primarily centered on high-demand therapeutic areas such as diabetes, obesity, and autoimmune disorders. Mile High Biopharmaceutical leverages advanced drug discovery platforms to advance a pipeline of small molecules and biologics through clinical development. Strategically located within the Chongqing International Biological Park, the company benefits from a robust regional ecosystem for biopharmaceutical innovation and commercialization. Their lead programs include candidates targeting the GLP-1 receptor and various inflammatory cytokines.